ESCRS Homepage

March 2003
IN THIS ISSUE

New ESCRS trial in bid to cut endophthalmitis rate to 0.01%


Lasik corrects refractive errors after PK in selected patients

Africa-Luz mobilises to provide eye care in regions riven by poverty

Multifocal IOL
choice hinges on patterns of daily routine

Anti-histamine drug mitigates risk of developing DLK after Lasik, says study

Untreated eyelid inflammatory disorders pose risk for postoperative complications

Thermotopography shows ‘enormous promise’
for diagnosis and treatment of eye diseases

Lasik offers ‘very effective treatment’ for
refractive errors after PK, says US specialist

Good results with PRK and Lasek rival Lasik for top spot in refractive excimer laser surgery

Orbital lymphomas respond well to local, systemic therapies, says study

Laser technologies still beam but economy and consumer demand will determine future of refractive surgery

Legally blind cardiologist finds new beat in low vision rehabilitation

‘Pivotal’ anti-TGF antibody therapy reduces
filtering bleb wound formation, says report

Neuroprotective agents stem optic nerve damage
by ‘offering a solution’ to open-angle glaucoma

Echothiophate iodide shortage leaves US specialists struggling to find alternative for acute cases

Postoperative complications of PK will have serious consequences unless tackled 'aggressively’

Private refractive clinics claim young specialists as public waiting lists grow in Canadian eye surgery

German doctors’ helpers oil the cogs of the private ophthalmic practice

Study of 900 ICLs reveals good safety and long-term refractive results, says Spanish specialist

New toric IOL corrects high corneal astigmatism after cataract surgery, Austrian study reveals

IVF children run increased risk of developing
retinoblastoma, claim Dutch researchers

Suture-free DLEK preserves corneal surface topography and ensures faster wound healing

The day I said goodbye to cataracts and hello to the world without glasses

Retina specialists and trauma ophthalmologists
prepare to trade notes at joint Hungarian conference

Night blindness casts bogeyman into the shadows

Erbium laser phaco requires longer time but less energy for moderately hard cataracts

FEATURES
From The Editor
Reflections on Refractive Surgery
In Your Good Books
Bio-ophthalmology
In The Driving Seat
Prime Site
The Collector's Eye
Regulatory Matters



Lasik corrects refractive errors after PK in selected patients

Ana Hidalgo-Simón MD, PhD in Gatwick, London

DATA compiled from a recent UK study shows that Lasik is effective in correcting refractive errors like anisometropia and astigmatism after PK, provided patients are chosen carefully, Marcela Espinosa MD told the Cornea 2002 meeting.
Dr Espinosa and Sheraz Daya MD, from the Centre for Sight, Queen Victoria Hospital, East Grinstead, UK were concerned about the unpredictability of the correction of refractive errors following PK.
Current therapeutic options for these patients include astigmatic keratotomy, re-graft, lensectomy with toric IOL implantation, wedge resection, photorefractive keratotomy and Lasik.

“We found that PRK used to treat refractive errors following PK resulted in persistent epithelial defects and a substantial amount of inflammation. This modality also had limited scope for correction and frequently resulted in haze or scarring.
“Although still controversial, we found that Lasik resulted in less inflammation. We could also perform an increased range of corrections and early enhancements when necessary. In addition, Lasik could be combined with other therapeutic interventions, such as astigmatic keratotomy,” she explained.

The study included 62 eyes of 57 patients. Exclusion criteria were poor graft-host apposition, areas of thinning, large pupils, any graft rejection within the previous 12 months and the presence of systemic or ocular surface diseases.
The most common original diagnosis was keratoconus which occurred in 72.6% of cases, followed by herpes virus keratitis, corneal dystrophy and trauma.
The mean age of participants was 42 years, ranging between 22 and 85, and mean time after PK was 7.6 years, ranging between two and 23.
Preoperative mean sphere was -3.04 D (range –15.75 to 7.75); mean cylinder was -4.91 D (range 0.0 D to –13.0 D); and mean spherical equivalent (SE) was -5.50 D (range -17.0 D to 5.8 D).

The follow-up period ranged from six to 60 months and averaged at 27 months, with visits at one day, one week and then one, three, six, 12 and 24 months.
Enhancements, when necessary, were performed at three months postoperatively. The follow-up rate at last visit was relatively poor at 44 eyes or 71%.
All operations were performed with one of two lasers (LS 2000: LaserSight and Technolas 217: Bausch and Lomb) and one of three microkeratomes (Chiron ACS: Bausch and Lomb; Flapmaker: Refractive Technologies; and Hansatome: Bausch and Lomb), although the majority of the operations were performed with the Hansatome.
“Although there wasn’t a large change between the before and after cylinder measurements (-4.91 D and –3.22 D), the decrease in standard deviation was significant. We had to take into consideration the fact that these eyes have big refractive errors before the Lasik,” she explained.

Stability over time was excellent, with a slight drift towards myopia after two years. Not too many eyes had data for more than two years, so these results need to be confirmed.
Predictability after one and three months and one year was also good. There was a tendency towards undercorrection, which remained stable over time, she reported.
Safety evaluations were performed at one, three, six and months postoperatively. These studies revealed that between 20% and 50% of eyes showed no change in acuity.
Approximately one third of patients gained one line of vision, with a few patients gaining two or more lines.

The UCVA results were good. Some 30% of the eyes saw 20/40 or better at six months, improving to 40% at one year. BCVA was 20/40 or better in 96% of eyes after one year. In 22.6% of eyes, re-treatment was necessary (twice in two eyes) and in 16% a combined procedure with astigmatic keratotomy (AK) was used.
The complications encountered by Dr Espinosa and her team included one free flap, three partial flaps and three buttonholes. All these were treated and corrected without further problems. They also had three cases of epithelial in-growth, one rejection episode, and one case of herpes simplex virus infection. Four eyes required re-grafting.
“There is a certain amount of controversy about when to use Lasik after PK. The traditional view recommends waiting some time, giving the eye a rest to recover after the cut of the flap. We did not think this was necessary. Currently, our re-treatment rate is 13%. If we wait, that rate of re-intervention would be 100%,” she explained.

She said that exposing the eye twice is hazardous for the allograft, with its subsequent inflammation and antigen presentation.

The data from the current study indicates that Lasik is effective in reducing the refractive error after PK, but not for all patients. There is an increased chance of flap complications. Lasik can be combined with other techniques, such as under-flap AK, and more effectively, bitoric ablations, she explained.
“The important point is to understand that, assuming you are selective with patients, this technique reduces anisometropia, reduces astigmatism and helps patients tolerate their spectacles better,” Dr Espinosa said.


Marcela Espinosa MD
Centre for Sight, Queen Victoria Hospital, UK
Email: marcela@centreforsight.com

 

Top